Privia Health Group, Inc. — Director's Dealing 2025

Dec 16, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Privia Health Group, Inc. (PRVA)
CIK: 0001759655
Period of Report: 2025-12-12

Reporting Person: Morris Matthew Shawn (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-12	Common Stock, par value $0.01 per share	M	13647	$2	Acquired	81835	Direct
2025-12-12	Common Stock, par value $0.01 per share	S	13647	$25.01	Disposed	68188	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-12-12	Stock Option (Right to Purchase)	$2	M	13647	Disposed	2033-08-27	Common Stock, par value $0.01 per share (13647)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.01 per share	12487	Indirect
Common Stock, par value $0.01 per share	11998	Indirect

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.105 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3: All of the stock options are fully vested and exercisable.